The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders
Open accessAbstract
Summary: Understanding cytokine immunobiology is central to the development of rational therapies for destructive inflammatory diseases such as rheumatoid arthritis (RA) and periodontitis. The classical interleukin-1 (IL-1) family cytokines, IL-1α and IL-1β, as well as IL-18, play key roles in inflammation. Recently, other members of the IL-1 family have been identified. These include six cytokines whose genes are located downstream of the genes for IL-1α and IL-1β on chromosome 2 (IL-1F5-10) and also IL-33, which is the ligand for ST2, a member of the IL-1R/Toll-like receptor (TLR) receptor superfamily. IL-1F6, IL-1F8 and Il−1F9 are agonists and, along with their receptor IL-1Rrp2, are highly expressed in epithelial cells suggesting a role in immune defence in the skin and the gastrointestinal (GI) tract including the mouth. Synovial fibroblasts and articular chondrocytes also express IL-1Rrp2 and respond to IL-1F8, indicating a possible role in RA. IL-33 is associated with endothelial cells in the inflamed tissues of patients with RA and Crohn's disease, where it is a nuclear factor which regulates transcription. IL-33 is also an extracellular cytokine: it induces the expression of T helper 2 (Th2) cytokines in vitro and in vivo as well as histopathological changes in the lungs and GI tract of mice. Therapeutic agents which modify IL-1 cytokines (e.g. recombinant IL-1Ra) have been used clinically and others are at various stages of development (e.g. anti-IL-18 antibodies). This review highlights the emerging data on these novel IL-1 cytokines and assesses their possible role in the pathogenesis and therapy of destructive inflammatory disorders such as RA and periodontitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Pihlstrom, B. L., Michalowicz, B. S., & Johnson, N. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67728-8 · Cited by 3,522
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue Destruction
Graves, D. T., & Cochran, D. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.3.391 · Cited by 1,003
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., & Brenner, M. B. (2002) · Science · doi:10.1126/science.1073176 · Cited by 750
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
The host response to the microbial challenge in periodontitis: assembling the players
KORNMAN, K. S., PAGE, R. C., & TONETTI, M. S. (1997) · Periodontology 2000 · doi:10.1111/j.1600-0757.1997.tb00191.x · Cited by 657
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X.-Q., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 636
Gracie, J. A., Robertson, S. E., & McInnes, I. B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602313 · Cited by 603
Assuma, R., Oates, T., Cochran, D., Amar, S., & Graves, D. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.403 · Cited by 600
The IL-1 family and inflammatory diseases.
Dinarello, C. A. (2002) · PubMed · Cited by 599
Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzymea
DINARELLO, C. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08307.x · Cited by 498
Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D., & Sims, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400117200 · Cited by 419
Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., & Rubartelli, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308558101 · Cited by 409
Puren, A. J., Fantuzzi, G., & Dinarello, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2256 · Cited by 379
Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family
Kumar, S., McDonnell, P. C., Lehr, R., Tierney, L., Tzimas, M. N., Griswold, D. E., Capper, E. A., Tal-Singer, R., Wells, G. I., Doyle, M. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10308 · Cited by 364
Four New Members Expand the Interleukin-1 Superfamily
Smith, D. E., Renshaw, B. R., Ketchem, R. R., Kubin, M., Garka, K. E., & Sims, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1169 · Cited by 341
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Interleukin‐18 and Host Defense against Infection
Dinarello, C. A., & Fantuzzi, G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374751 · Cited by 287
Debets, R., Timans, J. C., Homey, B., Zurawski, S., Sana, T. R., Lo, S., Wagner, J., Edwards, G., Clifford, T., Menon, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1440 · Cited by 286
Periodontitis and Rheumatoid Arthritis: A Review
Bartold, P. M., Marshall, R. I., & Haynes, D. R. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.11-s.2066 · Cited by 285
Targeting signal transduction as a strategy to treat inflammatory diseases
O'Neill, L. A. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2070 · Cited by 283
The role of interleukin-1 in the pathogenesis of rheumatoid arthritis
Kay, J. (2004) · Rheumatology · doi:10.1093/rheumatology/keh201 · Cited by 280
Host response modulation in the management of periodontal diseases
Salvi, G. E., & Lang, N. P. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00785.x · Cited by 276
Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease
Gemmell, E., & Seymour, G. J. (2004) · Periodontology 2000 · doi:10.1111/j.0906-6713.2004.003557.x · Cited by 273
Cloning the interleukin 1 receptor from human T cells.
Sims, J. E., Acres, R. B., Grubin, C. E., McMahan, C. J., Wignall, J. M., March, C. J., & Dower, S. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8946 · Cited by 265
The Role of Local Drug Delivery in the Management of Periodontal Diseases: A Comprehensive Review
Greenstein, G., & Polson, A. (1998) · Journal of Periodontology · doi:10.1902/jop.1998.69.5.507 · Cited by 261
Kumar, S., Hanning, C. R., Brigham-Burke, M. R., Rieman, D. J., Lehr, R., Khandekar, S., Kirkpatrick, R. B., Scott, G. F., Lee, J. C., Lynch, F. J., et al. (2002) · Cytokine · doi:10.1006/cyto.2002.0873 · Cited by 259
Brook, M., Tchen, C. R., Santalucia, T., McIlrath, J., Arthur, J. S. C., Saklatvala, J., & Clark, A. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2408-2418.2006 · Cited by 250
Delima, A. J., Oates, T., Assuma, R., Schwartz, Z., Cochran, D., Amar, S., & Graves, D. T. (2001) · Journal of Clinical Periodontology · doi:10.1034/j.1600-051x.2001.028003233.x · Cited by 233
Annotating genes with potential roles in the immune system: six new members of the IL-1 family
Dunn, E., Sims, J. E., Nicklin, M. J. H., & O'Neill, L. A. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02034-8 · Cited by 233
TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN INFLAMMATION
Kracht, M., & Saklatvala, J. (2002) · Cytokine · doi:10.1006/cyto.2002.0895 · Cited by 229
Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., & Tominaga, S.-I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81333-u · Cited by 219
Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member
Lin, H., Ho, A. S., Haley-Vicente, D., Zhang, J., Bernal-Fussell, J., Pace, A. M., Hansen, D., Schweighofer, K., Mize, N. K., & Ford, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010095200 · Cited by 218
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention
Braddock, M., & Quinn, A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1342 · Cited by 214
IL-1 and IL-18 receptors, and their extended family
Sims, J. E. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00306-5 · Cited by 211
A Sequence-Based Map of the Nine Genes of the Human Interleukin-1 Cluster
Nicklin, M. J. H., Barton, J. L., Nguyen, M., FitzGerald, M. G., Duff, G. W., & Kornman, K. (2002) · Genomics · doi:10.1006/geno.2002.6751 · Cited by 205
Post‐transcriptional regulation of gene expression by mitogen‐activated protein kinase p38
Clark, A. R., Dean, J. L. E., & Saklatvala, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00439-3 · Cited by 196
Interleukin 18: a pleiotropic participant in chronic inflammation
McInnes, I. B., Gracie, J. A., Leung, B. P., Wei, X.-Q., & Liew, F. Y. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01648-0 · Cited by 191
Stack, J. H., Beaumont, K., Larsen, P. D., Straley, K. S., Henkel, G. W., Randle, J. C. R., & Hoffman, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2630 · Cited by 190
Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases
Möller, B., & Villiger, P. M. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0012-9 · Cited by 183
Graves, D. T., Delima, A. J., Assuma, R., Amar, S., Oates, T., & Cochran, D. (1998) · Journal of Periodontology · doi:10.1902/jop.1998.69.12.1419 · Cited by 182
A new nomenclature for IL-1-family genes
Sims, J. E., Pan, Y., Smith, D. E., Nicklin, M. J. H., Barton, J. L., Bazan, J. F., Kastelein, R. A., Busfield, S. J., Ford, J. E., Lin, H., et al. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02040-3 · Cited by 181
Molecular and cell biology of healthy and diseased periodontal tissues
Bartold, P. M., & Narayanan, A. S. (2006) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00140.x · Cited by 179
Orozco, A., Gemmell, E., Bickel, M., & Seymour, G. J. (2006) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2006.00292.x · Cited by 177
Is IL-1 a good therapeutic target in the treatment of arthritis?
Burger, D., Dayer, J.-M., Palmer, G., & Gabay, C. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.004 · Cited by 175
A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST2
Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B., & Liew, F. Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.145 · Cited by 168
Molecular and cellular basis of rheumatoid joint destruction
Karouzakis, E., Neidhart, M., Gay, R. E., & Gay, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.011 · Cited by 167
Marotte, H., Farge, P., Gaudin, P., Alexandre, C., Mougin, B., & Miossec, P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036913 · Cited by 165
T1/ST2—an IL-1 receptor-like modulator of immune responses
Trajkovic, V., Sweet, M. J., & Xu, D. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.02.004 · Cited by 161
Porphyromonas gingivalis-Epithelial Cell Interactions in Periodontitis
Andrian, E., Grenier, D., & Rouabhia, M. (2006) · Journal of Dental Research · doi:10.1177/154405910608500502 · Cited by 158
Genomic Organization of the Interleukin-1 Locus
Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E., & Sims, J. E. (2002) · Genomics · doi:10.1006/geno.2002.6752 · Cited by 154
Magne, D., Palmer, G., Barton, J. L., Mézin, F., Talabot‐Ayer, D., Bas, S., Duffy, T., Noger, M., Guerne, P., Nicklin, M. J. H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1946 · Cited by 146
An IL-1 Family Member Requires Caspase-1 Processing and Signals through the ST2 Receptor
Dinarello, C. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.004 · Cited by 132
Cho, M.-C., Jung, Y. H., MOON, Y., Min, S., YOON, C., LEE, S., PARK, S., CHO, C., Jue, D., & KIM, H. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.020 · Cited by 129
O'Neill, L. A. J. (2000) · Science s STKE · doi:10.1126/stke.442000re1 · Cited by 126
Davis, C. N., Mann, E., Behrens, M. M., Gaidarova, S., Rebek, M., REBEK, J. J., & Bartfai, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510802103 · Cited by 124
Kumar, A., Lnu, S., Malya, R., Barron, D. A., Moore, J., Corry, D. B., & Boriek, A. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1148com · Cited by 107
Yanagisawa, K., Naito, Y., Kuroiwa, K., Arai, T., Furukawa, Y., Tomizuka, H., Miura, Y., Kasahara, T., Tetsuka, T., & Tominaga, S.-I. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021577 · Cited by 107
Antigen‐presentation and the role of dendritic cells in periodontitis
Cutler, C. W., & Jotwani, R. (2004) · Periodontology 2000 · doi:10.1111/j.0906-6713.2004.003560.x · Cited by 105
The many worlds of reducing interleukin‐1
Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21107 · Cited by 104
Vos, J. B., van Sterkenburg, M. A. J. A., Rabe, K. F., Schalkwijk, J., Hiemstra, P. S., & Datson, N. A. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00289.2004 · Cited by 94
Cytokine gene polymorphism and immunoregulation in periodontal disease
Taylor, J. J., Preshaw, P. M., & Donaldson, P. T. (2004) · Periodontology 2000 · doi:10.1111/j.0906-6713.2004.003561.x · Cited by 89
Self-citationInterleukin‐18 Concentrations and the Pathogenesis of Periodontal Disease
Johnson, R. B., & Serio, F. G. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.5.785 · Cited by 81
Caspase Inhibitors: A Pharmaceutical Industry Perspective
LINTON, S. J. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802605775009720 · Cited by 79
Takezako, N., Hayakawa, M., Hayakawa, H., Aoki, S., Yanagisawa, K., Endo, H., & Tominaga, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.206 · Cited by 77
WANG, P., Meinhardt, B., André, R., Renshaw, B. R., Kimber, I., Rothwell, N. J., & Pinteaux, E. (2005) · Cytokine · doi:10.1016/j.cyto.2004.12.002 · Cited by 35
Interleukin-12 to interleukin ‘infinity’: the rationale for future therapeutic cytokine targeting
Anderson, E. J. R., McGrath, M., Thalhamer, T., & McInnes, I. B. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0011-x · Cited by 21
Waterman, W. R., Xu, L. L., Tetradis, S., Motyckova, G., Tsukada, J., Saito, K., Webb, A. C., Robinson, D. R., & Auron, P. E. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.003 · Cited by 17
Anakinra for the treatment of neonatal-onset multisystem inflammatory disease
Hoffman, H. M., & Firestein, G. S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0350 · Cited by 9
Cited by
Regulation of intestinal epithelial permeability by tight junctions
Suzuki, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1070-x · Cited by 1,343
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
Lee, S. H. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.11 · Cited by 807
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Metadata
- Authors
- Barksby, H. E., Lea, S. R., Preshaw, P. M., & Taylor, J. J.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-22
- Volume
- 149
- Issue
- 2
- Pages
- 217-225
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2060218189
- Cited by
- 371
- References
- 78
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.